Dexmetomidine in Children Undergoing General Anaesthesia

• Status: Completed
• Trial end date: 2020-09-25
• Target enrollment: 0
• Participant gender: All

Summary

The effects of dexmedetomidine on the onset of both the general anaesthesia induction and the neuromuscular blockade in children of school age will be investigated. Ten minutes before the induction of general anaesthesia, the first group will receive continuous infusion of dexmedetomidine (DEX group), while the second group will receive normal saline (Placebo group).

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Attikon Hospital
• Treatments: Anesthetics; Dexmedetomidine

Criteria

Inclusion Criteria:

• children underoing elective surgery under general anaesthsia

• age 4-12 years old

• ASA I-II

Exclusion Criteria:

• patient or parent refusal

• Mallampati score> 3

• BMI>35

• severe systemic cardiac disease

• neuromuscular disease

• recent respiratory infection

• drug allergy